Provided are compounds of the Formula (I); or pharmaceutically acceptable salts thereof, which are useful for the inhibition of DHX9 and in the treatment of a variety of DHX9 mediated conditions or diseases, such as cancer.
Design and synthesis of substituted pyridine derivatives as HIF-1α prolyl hydroxylase inhibitors
摘要:
Structure-guided de novo drug design led to the identification of a novel series of substituted pyridine derivatives as HIF-1 alpha prolyl hydroxylase inhibitors. Pyridine carboxyamide derivatives bearing a substituted aryl group at the 5-position of the pyridine ring show appreciable activity, while constraining the side chain by placing a pyrazole carboxylic acid generated a potent lead series with consistent activity against EGLN-1. (c) 2006 Elsevier Ltd. All rights reserved.